| Heading: |
Pancreatic Cancer: Clinical Trials and Research |
| Question ID: |
1783533 |
| UIN: |
37508 |
| House: |
Commons |
| Date tabled: |
2025-03-11 |
| Asking Member ID: |
5361 |
| Asking Member display name: |
James McMurdock
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
James McMurdock
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure patients diagnosed with pancreatic cancer access (a) relevant research and (b) clinical trials. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-03-25 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department invests £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £133 million in 2023/24, reflecting its high priority.Re... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |